All (N = 147) | IDH (−) (N = 97) | IDH (+) (N = 50) | |
---|---|---|---|
Age (y) | 70.9 ± 11.1 | 71.1 ± 11.0 | 70.6 ± 11.4 |
Male/female | 90/57 | 61/36 | 29/21 |
Time since starting HD (months) | 112 (68–167) | 121 (74–173) | 108 (60–157) |
Diabetes mellitus | 63 (42.9) | 35 (36.1) | 28 (56.0) |
Hypertension | 131 (89.1) | 84 (86.6) | 47 (94.0) |
Smoking | 60 (40.8) | 40 (41.2) | 20 (40.0) |
History | |||
CVD (%) | 55 (37.4) | 31 (32.0) | 24 (48.0) |
PAD (%) | 16 (10.9) | 6 (6.1) | 10 (20.0) |
Medication | |||
Antiplatelet agents (%) | 88 (59.8) | 57 (58.8) | 31 (62.0) |
ARB (%) | 95 (64.6) | 61 (62.9) | 34 (68.0) |
ACEI (%) | 7 (4.8) | 5 (5.2) | 2 (4.0) |
CCB (%) | 83 (56.5) | 59 (60.8) | 24 (48.0) |
β-blocker (%) | 44 (29.9) | 31 (32.0) | 13 (26.0) |
Characteristics on dialysis | |||
IDWG (%) | 3.91 ± 1.39 | 3.74 ± 1.36 | 4.25 ± 1.41 |
Systolic BP (mmHg) | 142.3 ± 19.9 | 141.6 ± 18.3 | 143.6 ± 23.0 |
Diastolic BP (mmHg) | 74.7 ± 13.2 | 75.6 ± 12.1 | 72.9 ± 15.3 |
Blood flow rate (mL/min) | 213 ± 33 | 215 ± 33 | 208 ± 32.8 |
Kt/V urea | 1.51 ± 0.26 | 1.50 ± 0.27 | 1.52 ± 0.25 |
Dialyzer: PS/PES | 105 (71.4%) | 74 (76.3) | 31 (62.0) |
Dialyzer: cellulose triacetate | 35 (23.8%) | 18 (18.6) | 17 (34.0) |
IDH | 50 (34.5%) | 0 (0%) | 50 (100%) |
Laboratory data | |||
Albumin (g/dL) | 3.68 ± 0.29 | 3.72 ± 0.24 | 3.58 ± 0.36 |
Corrected Calcium (mg/dL) | 8.33 ± 0.68 | 8.32 ± 0.68 | 8.35 ± 0.70 |
Phosphate (mg/dL) | 5.28 ± 1.02 | 5.20 ± 0.96 | 5.44 ± 1.13 |
Intact PTH (pg/mL) | 204.3 ± 126.9 | 201.2 ± 119.7 | 210.4 ± 141.0 |
HDL-C (mg/dL) | 48.5 ± 13.8 | 49.5 ± 14.5 | 46.6 ± 12.4 |
LDL-C (mg/dL) | 78.3 ± 23.2 | 81.0 ± 23.2 | 73.3 ± 22.8 |
Glycoalbumin (%) | 17.9 ± 4.7 | 17.5 ± 4.4 | 18.9 ± 5.2 |
Hemoglobin (g/dL) | 11.1 ± 0.79 | 11.1 ± 0.82 | 11.2 ± 0.72 |
β2-microglobulin (mg/L) | 27.2 ± 5.10 | 26.8 ± 5.15 | 28.0 ± 4.95 |